COVID-19. covid-19
Conditions
Interventions
Intervention 1: Case group: The Isfahan educational hospital staff who are at risk of coronavirus receiving 200 mg of hydroxychloroquine tablets (Amin Pharmaceutical Company) orally twice a week for
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Signing the consent form of high-risk personnel and exposed to the virus
Exclusion criteria
Exclusion criteria: Treatment with other antiviral drugs at the same time, except for the drugs prescribed in the national protocol Concomitant diseases: malignancy, advanced heart failure, cirrhosis, people under dialysis, stroke, Alzheimer's, progressive chronic neurological diseases Evidence of multi-organ failure Pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The onset of covid-19 infection. Timepoint: Before study and after 3 and 6 months. Method of measurement: Clinical symptoms, Corona PCR, CT scan of the lungs. | — |
Secondary
| Measure | Time frame |
|---|---|
| The severity of COVID-19. Timepoint: Before study and after 3 and 6 months. Method of measurement: Clinical feature, CT scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElahe Nasri
Esfahan University of Medical Sciences
Outcome results
None listed